Göran Tornling
Director/Board Member at ACUCORT AB
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gunilla Anders Ekström | M | 66 |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden.
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden.
Karolinska Institutet
| 21 years |
| Urban Paulsson | M | 60 |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | 7 years |
| Nikolaj Sørensen | M | 52 |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden.
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | - |
| Ulf Ljungberg | M | - |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | 9 years |
| Peter Sjöstrand | M | 78 |
Karolinska Institutet
| - |
| Denise Goode | F | 66 |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | 9 years |
| Anders Olof Adolf Ekblom | M | 70 |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden.
Karolinska Institutet
| 10 years |
| Charlotte Elisabet Edenius | M | 66 |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | 7 years |
| Ralf Morgenstern | M | - |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | 7 years |
| Anna Martling | M | 55 |
Karolinska Institutet
| - |
| Patric Stenberg | M | - |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | 7 years |
| Hans Lennart Rudolf Wigzell | M | 86 |
Karolinska Institutet
| 29 years |
| Thomas Perlmann | M | - |
Karolinska Institutet
| - |
| Klas Kärre | M | 70 |
Karolinska Institutet
| - |
| Lena Von Koch | F | - |
Karolinska Institutet
| - |
| Jonas Jonas Jönmark | M | 53 | 4 years | |
| Rune Toftgard | M | - |
Karolinska Institutet
| - |
| Ebba Cecilia Fåhraeus | F | 61 | 6 years | |
| Björn Allan Beermann | M | 83 |
Karolinska Institutet
| - |
| Hans Ehrsson | M | - |
Karolinska Institutet
| - |
| Jan Peter Andersson | M | 73 |
Karolinska Institutet
| 14 years |
| Peter Hjelmström | M | 51 |
Karolinska Institutet
| - |
| Jan Matthew Balmanno Carlstedt-Duke | M | 71 |
Karolinska Institutet
| - |
| Lars Ährlund-Richter | M | 72 |
Karolinska Institutet
| - |
| Håkan Mellstedt | M | 82 |
Karolinska Institutet
| 25 years |
| Roger Franklin | M | 45 |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | - |
| Pär Nordlund | M | 66 |
Karolinska Institutet
| 19 years |
| Eva Andersson-Dubin | M | - |
Karolinska Institutet
| - |
| Hans Wiksell | M | - |
Karolinska Institutet
| - |
| Han Jing Xie | M | 54 |
Karolinska Institutet
| - |
| Gert Auer | M | - |
Karolinska Institutet
| - |
| Hans Hassle | M | - |
Karolinska Institutet
| - |
| Gunnar Olof Olsson | M | 71 |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | - |
| Kerstin Uvnäs Moberg | M | 80 |
Karolinska Institutet
| - |
| Joakim Tedroff | M | 63 |
Karolinska Institutet
| - |
| Anders Blanck | M | - |
Karolinska Institutet
| - |
| Alexandra Johnsson | F | 53 | 6 years | |
| Anna-Karin Edstedt Bonamy | M | 50 |
Karolinska Institutet
| 10 years |
| Peter Sackey | M | 53 |
Karolinska Institutet
| - |
| Ronald Li | M | - |
Karolinska Institutet
| 8 years |
| Susana Borrás | F | - |
Karolinska Institutet
| - |
| Olle Kämpe | M | 68 |
Karolinska Institutet
| - |
| Magnus Sjoegren | M | - |
Karolinska Institutet
| - |
| Tord Stefan Erik Arver | M | 72 |
Karolinska Institutet
| - |
| Marie Wickman-Chanteraeu | M | 69 |
Karolinska Institutet
| - |
| Ewa Björling | M | 63 |
Karolinska Institutet
| - |
| Johan Edvard Lundin | M | 60 |
Karolinska Institutet
| 12 years |
| Ralf Morgenstern | M | 72 |
Karolinska Institutet
| - |
| Magnus Westgren | M | 73 |
Karolinska Institutet
| 18 years |
| Magnus Jaderberg | M | - |
Karolinska Institutet
| - |
| Scott Boyer | M | 62 |
Karolinska Institutet
| - |
| Carani Sanjeevi | M | 66 |
Karolinska Institutet
| 28 years |
| Bengt Ingemar Samuelsson | M | 90 |
Karolinska Institutet
| - |
| Monica Kristina Wallter | M | 68 | 3 years | |
| Rolf Valter Rikard Kiessling | M | 76 |
Karolinska Institutet
| 30 years |
| Josef M. Miller | M | - |
Karolinska Institutet
| - |
| Roger William Gunnarsson | M | 77 |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | - |
| Lars-Olof Hansson | M | 80 |
Karolinska Institutet
| 26 years |
| Bo Angelin | M | 73 |
Karolinska Institutet
| - |
| Andris Kreicbergs | M | - |
Karolinska Institutet
| - |
| Kenneth R. Chien | M | - |
Karolinska Institutet
| - |
| Sven-Erik Dahlén | M | - |
Karolinska Institutet
| - |
| Jonas Karl Olaf Brambeck | M | 66 |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | - |
| Jonas Christopher Frisén | M | 58 |
Karolinska Institutet
| - |
| Håkan Elmqvist | M | - |
Karolinska Institutet
| - |
| Gunnar Magnus Modee Persson | M | 64 |
Karolinska Institutet
| 30 years |
| Carl Johan Bertil Sundberg | M | 66 |
Karolinska Institutet
| - |
| Stig Gösta Ollmar | M | 78 |
Karolinska Institutet
| 27 years |
| Madeleine Olsson-Eriksson | M | 79 |
Karolinska Institutet
| - |
| Bo-Ragnar Tolf | M | 74 |
Karolinska Institutet
| - |
| Anders Vahlne | M | 78 |
Karolinska Institutet
| 30 years |
| Matti Sällberg | M | 63 |
Karolinska Institutet
| 24 years |
| Anna Maria Albertina Eriksrud | F | 66 | 7 years | |
| Bernd Seizinger | M | 67 |
Karolinska Institutet
| - |
| Per M. Almqvist | M | - |
Karolinska Institutet
| - |
| Jan Anders Holgersson | M | - |
Karolinska Institutet
| - |
| Sven Fredrik Lindskog | M | 71 |
Karolinska Institutet
| - |
| Lars Gunnar Lannfelt | M | 75 |
Karolinska Institutet
| 31 years |
| David Rikard Martinsson Holmdahl | M | 71 |
Karolinska Institutet
| 16 years |
| John Arne Øvretveit | M | - |
Karolinska Institutet
| - |
| John Wahren | M | - |
Karolinska Institutet
| - |
| Graham Lappin | M | - |
Karolinska Institutet
| - |
| Lennart Hammarstrom | M | - |
Karolinska Institutet
| - |
| Ulf de Faire | M | - |
Karolinska Institutet
| - |
| Mona Ståhle | M | - |
Karolinska Institutet
| - |
| Gunvor Ester Ekman-Ordeberg | M | 80 |
Karolinska Institutet
| 23 years |
| Torkel Klingberg | M | - |
Karolinska Institutet
| - |
| Lars Olov Larsson | M | - |
Karolinska Institutet
| - |
| Sten Nilsson | M | 76 |
Karolinska Institutet
| - |
| Erik Gustav Magnus Axelson | M | - |
Karolinska Institutet
| - |
| Edvard Smith | M | 73 |
Karolinska Institutet
| - |
| Erik Johan Frostegård | M | 65 |
Karolinska Institutet
| - |
| Marie Monika Anna Encrantz | F | - |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | - |
| Torgny H. Svensson | M | - |
Karolinska Institutet
| - |
| Klas Gosta Wiman | M | - |
Karolinska Institutet
| - |
| Staffan Encrantz | M | 72 |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | - |
| Ola Winqvist | M | 58 |
Karolinska Institutet
| - |
| Lajos Gunnar Németh | M | 72 |
Karolinska Institutet
| 21 years |
| Lars Olson | M | - |
Karolinska Institutet
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Torbjørn Bjerke | M | 61 |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Göran Tornling
- Personal Network
